indomethacin , 0.25 % administered topically completely inhibited the release of prostaglandin-like substances but was found to have inconsistent inhibitory effects on the clinical signs of inflammation and on the blood-aqueous barrier .
C0021246
indomethacin
C0021368
inflammation